Wesana Health Holdings Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WSNAF research report →
Companywww.wesanahealth.com
Wesana Health Holdings Inc, a life sciences company, engages in the development and delivery of psychedelic medicines and psilocybin-assisted psychotherapies to treat traumatic brain injuries. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is based in Chicago, Illinois.
- CEO
- Daniel Carcillo
- IPO
- 2021
- Employees
- 7
- HQ
- Chicago, IL, US
Price Chart
Valuation
- Market Cap
- $341.00K
- P/E
- -0.33
- P/S
- 0.00
- P/B
- -2.10
- EV/EBITDA
- -0.29
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -506.80%
- ROIC
- 4706.52%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,754,771 · 79.59%
- EPS
- $-0.05 · 79.13%
- Op Income
- $-1,124,906
- FCF YoY
- 88.74%
Performance & Tape
- 52W High
- $0.06
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.02
- Beta
- -0.71
- Avg Volume
- 8.23K
Get TickerSpark's AI analysis on WSNAF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our WSNAF Coverage
We haven't published any research on WSNAF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate WSNAF Report →